The use of a peptide vaccine that simultaneously targets PLK1 and blocks PD-L1 can lead to complete tumor eradication and long-term survival in mice with clonal heterologous C1498 myeloid leukemia (133). The gene discussed is PLK1; the disease is neoplasm.